In this context, it is noted that polymorphisms in genes including TGFBR2, TSPAN2, and PRDM16 are also associated with migraine risk (Gormley et al., 2016), underlining a potentially important role of these genes in migraine pathogenesis and therapy success in migraine. This evidence concerns the gene TSPAN2 and migraine disorder.